We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Surgical Robot Outperforms Human Surgeons in Precise Removal of Cancerous Tumors

By HospiMedica International staff writers
Posted on 20 Mar 2024

Surgically removing tumors from sensitive areas, such as the head and neck, poses significant challenges. More...

The goal during surgery is to take out the cancerous tissue while saving as much healthy tissue as possible. This balance is crucial because leaving behind too much cancerous tissue can lead to the cancer's return or spread. Doing a resection that has precise margins—specifically, a 5mm margin of healthy tissue—is essential but difficult. This margin, roughly the size of a pencil eraser, ensures that all cancerous cells are removed while minimizing damage. Tumors often have clear horizontal edges but unclear vertical boundaries, making depth assessment challenging despite careful pre-surgical planning. Surgeons can mark the horizontal borders but have limited ability to determine the appropriate depth for removal due to the inability to see beyond the surface. Additionally, surgeons face obstacles like fatigue and visual limitations, which can affect their performance. Now, a new robotic system has been designed to perform tumor removal from the tongue with precision levels that could match or surpass those of human surgeons.

The Autonomous System for Tumor Resection (ASTR) designed by researchers at Johns Hopkins (Baltimore, MD, USA) translates human guidance into robotic precision. This system builds upon the technology from their Smart Tissue Autonomous Robot (STAR), which previously conducted the first fully autonomous laparoscopic surgery to connect the two intestinal ends. ASTR, an advanced dual-arm, vision-guided robotic system, is specifically designed for tissue removal in contrast to STAR's focus on tissue connection. In tests using pig tongue tissue, the team demonstrated ASTR's ability to accurately remove a tumor and the required 5mm of surrounding healthy tissue. After focusing on tongue tumors due to their accessibility and relevance to experimental surgery, the team now plans to extend ASTR's application to internal organs like the kidney, which are more challenging to access. Combining ASTR's surgical precision with advanced imaging techniques could significantly advance tumor removal procedures.

“We’ve sent the robot to make an incision before, but this is the first time we’ve done a bulk resection and taken a tumor out fully,” said team leader Axel Krieger, assistant professor of mechanical engineering at the Whiting School of Engineering. “That’s the big novelty here.”

Related Links:
Johns Hopkins


Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Brain PET imaging could help identify Alzheimer’s patients most likely to benefit from available therapies (Image Credit: iStock)

Amyloid and Tau PET Guide Selection and Monitoring of Alzheimer’s Therapy

Alzheimer’s disease is the most common form of dementia and can be difficult to distinguish from other causes of cognitive decline. According to the World Health Organization (WHO), 57 million people were... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.